Products for Research Use Only
RegisterLogin

Quavonlimab

CAT: 0931-T81329-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T81329-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2254059-25-9
Target
Others
Related Pathways
Others
Purity
0.969
Bioactivity
Quavonlimab (MK-1308) is a novel human monoclonal antibody designed to selectively target and block the immune checkpoint molecule cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), investigation of quavonlimab in combination with the anti-PD-1 therapy KEYTRUDA (pembrolizumab) has shown encouraging anti-tumor activity along with an acceptable safety profile, making it an interesting compound for the reasearches into advanced non-small cell lung cancer (NSCLC) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
MBS5822982Quavonlimab
GTR18333802-01Quavonlimab Antibody
WA3401Research Grade Quavonlimab
E55B0906Quavonlimab (Reference antibody)
A138522Quavonlimab Biosimilar (Monoclonal, IgG1)
21-955Quavonlimab - Research Grade Biosimilar
ICH5794-20mgQuavonlimab Biosimilar - Research Grade
GTR18696571-01Quavonlimab Human Monoclonal Antibody
GTR18780307-01(Quavonlimab) Biosimilar Reference Antibody
C00747-1mgQuavonlimab (Anti-CTLA-4 / CD152)

Popular Products